ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/14 | 1,443 | 1,448 | 1,370 | 1,391 | -38 | -2.7% | 2,022,600 |
2023/11/13 | 1,530 | 1,532 | 1,410 | 1,429 | -73 | -4.9% | 2,575,600 |
2023/11/10 | 1,542 | 1,548 | 1,495 | 1,502 | -72 | -4.6% | 1,455,600 |
2023/11/09 | 1,558 | 1,574 | 1,543 | 1,574 | -17 | -1.1% | 870,700 |
2023/11/08 | 1,596 | 1,614 | 1,573 | 1,591 | -5 | -0.3% | 1,329,000 |
2023/11/07 | 1,538 | 1,675 | 1,531 | 1,596 | +89 | +5.9% | 5,954,200 |
2023/11/06 | 1,482 | 1,516 | 1,463 | 1,507 | +76 | +5.3% | 2,294,900 |
2023/11/02 | 1,415 | 1,441 | 1,399 | 1,431 | +33 | +2.4% | 749,300 |
2023/11/01 | 1,410 | 1,410 | 1,371 | 1,398 | +8 | +0.6% | 1,084,000 |
2023/10/31 | 1,341 | 1,395 | 1,339 | 1,390 | +54 | +4% | 846,300 |
2023/10/30 | 1,360 | 1,377 | 1,332 | 1,336 | -40 | -2.9% | 851,300 |
2023/10/27 | 1,328 | 1,376 | 1,308 | 1,376 | +36 | +2.7% | 995,400 |
2023/10/26 | 1,336 | 1,364 | 1,332 | 1,340 | -12 | -0.9% | 832,200 |
2023/10/25 | 1,379 | 1,383 | 1,349 | 1,352 | +3 | +0.2% | 548,800 |
2023/10/24 | 1,325 | 1,350 | 1,296 | 1,349 | +25 | +1.9% | 1,222,700 |
2023/10/23 | 1,344 | 1,358 | 1,310 | 1,324 | -20 | -1.5% | 928,400 |
2023/10/20 | 1,350 | 1,354 | 1,313 | 1,344 | -23 | -1.7% | 1,299,200 |
2023/10/19 | 1,386 | 1,400 | 1,367 | 1,367 | -41 | -2.9% | 976,500 |
2023/10/18 | 1,405 | 1,409 | 1,385 | 1,408 | +6 | +0.4% | 932,800 |
2023/10/17 | 1,409 | 1,421 | 1,375 | 1,402 | +11 | +0.8% | 1,050,100 |
2023/10/16 | 1,436 | 1,437 | 1,380 | 1,391 | -56 | -3.9% | 1,299,700 |
2023/10/13 | 1,467 | 1,470 | 1,442 | 1,447 | -31 | -2.1% | 701,400 |
2023/10/12 | 1,445 | 1,508 | 1,439 | 1,478 | +36 | +2.5% | 909,600 |
2023/10/11 | 1,432 | 1,444 | 1,422 | 1,442 | +5 | +0.3% | 752,700 |
2023/10/10 | 1,435 | 1,452 | 1,429 | 1,437 | +8 | +0.6% | 487,300 |
2023/10/06 | 1,450 | 1,456 | 1,421 | 1,429 | -12 | -0.8% | 614,000 |
2023/10/05 | 1,427 | 1,443 | 1,391 | 1,441 | +31 | +2.2% | 1,262,500 |
2023/10/04 | 1,412 | 1,434 | 1,403 | 1,410 | -24 | -1.7% | 1,319,200 |
2023/10/03 | 1,449 | 1,468 | 1,432 | 1,434 | -34 | -2.3% | 1,045,600 |
2023/10/02 | 1,500 | 1,507 | 1,465 | 1,468 | -24 | -1.6% | 893,600 |
2023/09/29 | 1,521 | 1,523 | 1,483 | 1,492 | -31 | -2% | 1,047,300 |
2023/09/28 | 1,538 | 1,544 | 1,515 | 1,523 | -23 | -1.5% | 570,900 |
2023/09/27 | 1,515 | 1,560 | 1,512 | 1,546 | +31 | +2% | 713,000 |
2023/09/26 | 1,529 | 1,538 | 1,510 | 1,515 | -22 | -1.4% | 812,400 |
2023/09/25 | 1,538 | 1,547 | 1,517 | 1,537 | -10 | -0.6% | 912,500 |
2023/09/22 | 1,541 | 1,577 | 1,534 | 1,547 | -20 | -1.3% | 898,100 |
2023/09/21 | 1,608 | 1,610 | 1,560 | 1,567 | -56 | -3.5% | 996,900 |
2023/09/20 | 1,601 | 1,633 | 1,592 | 1,623 | +17 | +1.1% | 805,400 |
2023/09/19 | 1,600 | 1,646 | 1,596 | 1,606 | +18 | +1.1% | 1,380,200 |
2023/09/15 | 1,572 | 1,616 | 1,562 | 1,588 | +23 | +1.5% | 4,525,100 |
2023/09/14 | 1,594 | 1,595 | 1,551 | 1,565 | -40 | -2.5% | 2,263,900 |
2023/09/13 | 1,631 | 1,637 | 1,575 | 1,605 | -22 | -1.4% | 1,887,200 |
2023/09/12 | 1,646 | 1,679 | 1,626 | 1,627 | +2 | +0.1% | 1,345,000 |
2023/09/11 | 1,639 | 1,647 | 1,614 | 1,625 | -13 | -0.8% | 683,400 |
2023/09/08 | 1,648 | 1,671 | 1,633 | 1,638 | -14 | -0.8% | 902,100 |
2023/09/07 | 1,648 | 1,664 | 1,641 | 1,652 | -5 | -0.3% | 740,400 |
2023/09/06 | 1,693 | 1,703 | 1,657 | 1,657 | -23 | -1.4% | 904,100 |
2023/09/05 | 1,651 | 1,683 | 1,651 | 1,680 | +17 | +1% | 719,100 |
2023/09/04 | 1,657 | 1,683 | 1,651 | 1,663 | +5 | +0.3% | 924,400 |
2023/09/01 | 1,658 | 1,663 | 1,629 | 1,658 | -2 | -0.1% | 1,033,500 |
251~
300
件表示中 / 4975件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 332,000円 | +3.0% | +27.5% | 2.41% | 21.02倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム